Table 2.
CNS medication use | Year 1 (n=3055)% | Year 2 (n=2911)% | Year 3 (n=2693)% | Year 5 (n=2480)% |
---|---|---|---|---|
Any CNS use | 13.88 | 14.50 | 16.30 | 18.02 |
Antidepressant use | 6.22 | 6.73 | 8.47 | 9.31 |
Antipsychotic use | 0.72 | 0.72 | 0.89 | 0.89 |
Benzodiazepine receptor agonist use | 5.99 | 6.05 | 6.13 | 6.73 |
Opioid analgesic receptor agonist use | 3.73 | 4.12 | 4.49 | 5.00 |
Use of 2+ agents | 2.98 | 3.85 | 4.34 | 4.29 |
High dose use (>3 SDD) | 2.39 | 2.85 | 3.04 | 3.43 |
Medium dose use (1–3 SDD) | 3.50 | 4.19 | 5.76 | 6.33 |
Low dose use (<1.0 SDD) | 7.99 | 7.46 | 7.50 | 8.27 |
Long term use (2+ years) | 7.79 | 10.07 | 11.33 | 11.33 |
Short-term use (<2 years) | 6.09 | 4.43 | 4.98 | 6.69 |
Abbreviations: CNS=central nervous system; SDD=standardized daily dose.